Skip to main content

Table 3 Antimicrobial susceptibility patterns of bacteria isolated from the urine of pregnant women at ANC clinic of HFSUH, Harar, Eastern Ethiopia, from November 2017 to January 2018

From: Prevalence of bacterial uropathogens and their antimicrobial susceptibility patterns among pregnant women in Eastern Ethiopia: hospital-based cross-sectional study

Isolated bacteria Total Pattern Antimicrobial agents tested
AMC
n (%)
AMP
n (%)
NOR
n (%)
CIP
n (%)
CN
n (%)
AK
n (%)
CRO
n (%)
CAZ
n (%)
SXT
n (%)
C
n (%)
NA
n (%)
F
n (%)
Escherichia coli 14 S
I
R
8(57.1)

6(42.9)
7(50)

7(50)
10(71.4)

4(28.6)
10(71.4)

4(28.6)
13(92.3)

1(7.7)
14(100)

10(71.4)
1(7.1)
3(21.5)
10(71.4)
1(7.13)
3(21.5)
6(42.9)
2(14.2)
6(42.9)
10(71.4)
2(14.3)
2(14.3)
6(42.9)
3(21.5)
5(3.6)
12(85.7)
2(14.3)
Proteus spp. 7 S
I
R
1(14.3)
2(28.6)
4(57.1)
2(28.6)
1(14.3)
4(57.1)
4(57.1)
1(14.3)
2(28.6)
4(57.1)
1(14.3)
2(28.6)
5(71.4)
2(28.6)
7(100)

3(42.9)
1(14.2)
3(42.9)
3(42.9)

4(57.1)
1(14.3)
1(14.3)
5(71.4)
4(57.1)

3(42.9)
1(14.3)
1(14.3)
5(71.4)
7(100)

Klebsiella pneumoniae 5 S
I
R
1(20)
1(20)
3(60)
1(20)

4(80)
3(60)

2(40)
3(60)
1(20)
1(20)
4(80)

1(20)
5(100)

3(60)

2(40)
3(60)

2(40)
3(60)
1(20)
1(20)
5(100)

1(20)
2(40)
2(40)
5(100)

Pseudomonas aeruginosa 2 S
I
R


2(100)


2(100)
1(50)

1(50)
1(50)

1(50)
1(50)

1(50)
1(50)

1(50)
2(100)

1(50)

1(50)
1(50)

1(50)
1(50)

1(50)
0(0)
1(50)
1(50)
1(50)

1(50)
Staphylococcus aureus 3 S
I
R
2(66.7)

1(33.3)
2(66.7)

1(33.3)
2(66.7)

1(33.3)
2(66.7)

1(33.3)
3(100)

3(100)

2(66.7)

1(33.3)
1(33.3)

2(66.6)
1(33.3)

2(66.7)
2(66.7)
1(33.3
1(33.3)
2(66.7)
3(100)

Total   S
I
R
12(38.7)
3(9.7)
15(51.6)
12(38.7)
1(3.2)
18(58.1)
20(64.5)
1(3.2)
10(32.3)
20(64.5)
2(6.5)
9(29)
26(83.9)
2(6.5)
3(9.7)
30(96.8)

1(3.2)
20(64.5)
2(6.5)
9(29)
18(58.1)
1(3.2)
12(38.7)
11(35.5)
4(12.9)
16(51.6)
22(71)
3(9.7)
6(19.4)
9(29)
9(29)
13(42)
28(9.1)
2(6.5)
1(3.2)
  1. AMC, amoxicillin-clavulanate; AMP, ampicillin; NOR, norfloxacin; CIP, ciprofloxacin; CN, gentamicin; AK, amikacin; CRO, ceftriaxone; CAZ, ceftazidime; SXT, cotrimoxazole; C, chloramphenicol; NA, nalixidic acid; F, nitrofurantoin; ‘–’, denotes 0(0)